Filing Details
- Accession Number:
- 0001246360-12-003643
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-28 18:30:15
- Reporting Period:
- 2012-08-24
- Filing Date:
- 2012-08-28
- Accepted Time:
- 2012-08-28 18:30:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 859368 | Medicis Pharmaceutical Corp | MRX | Pharmaceutical Preparations (2834) | 521574808 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1257563 | H Lottie Shackelford | 7720 N. Dobson Rd. Scottsdale AZ 85256 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-24 | 21,000 | $20.44 | 30,422 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-24 | 20,000 | $32.53 | 10,422 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Employee Director Option | Disposition | 2012-08-24 | 21,000 | $0.00 | 21,000 | $20.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-09-30 | 2012-09-30 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.37 to $32.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Billionaire Hedge Funds
